Auro Laboratories [AUROLAB] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Auro Laboratories Limited

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Auro Laboratories Limited wins in 8 metrics, Innova Captab Ltd. wins in 11 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Auro Laboratories Limited Innova Captab Ltd. Better
P/E Ratio (TTM) 48.08 31.20 Innova Captab Ltd.
Price-to-Book Ratio 3.57 4.05 Auro Laboratories Limited
Debt-to-Equity Ratio 100.84 32.95 Innova Captab Ltd.
PEG Ratio 0.01 1.33 Auro Laboratories Limited
EV/EBITDA 31.14 20.49 Innova Captab Ltd.
Profit Margin (TTM) 11.39% 8.85% Auro Laboratories Limited
Operating Margin (TTM) 32.83% 12.88% Auro Laboratories Limited
EBITDA Margin (TTM) 32.83% 12.88% Auro Laboratories Limited
Return on Equity 4.28% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 1.86% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-180.54M $-1.09B Auro Laboratories Limited
Dividend Yield N/A 0.30% N/A
1-Year Return 11.96% -3.19% Auro Laboratories Limited
Price-to-Sales Ratio (TTM) 5.48 2.76 Innova Captab Ltd.
Enterprise Value $2.03B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 7.13 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 88.05% 35.19% Auro Laboratories Limited
Revenue per Share (TTM) $46 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $5.20 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.09 -0.33 Innova Captab Ltd.

Auro Laboratories Limited vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

AUROLAB
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Auro Laboratories Limited-1.52%-3.45%6.14%-8.81%2.74%7.86%
Innova Captab Ltd.-0.63%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Auro Laboratories Limited11.96%219.81%161.67%1,083.37%3,551.32%4,900.00%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Auro Laboratories Limited vs Innova Captab Ltd.

MetricAUROLABINNOVACAP
Market Information
Market Cap i₹1.56B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,557578,151
90 Day Avg. Volume i4,543217,693
Last Close₹262.90₹857.00
52 Week Range₹159.00 - ₹317.00₹622.00 - ₹1,020.70
% from 52W High-17.07%-16.04%
All-Time High₹317.00 (Feb 18, 2026)₹1,260.00 (Jan 06, 2025)
% from All-Time High-17.07%-31.98%
Growth Metrics
Quarterly Revenue Growth2.08%0.42%
Quarterly Earnings Growth37.27%0.23%
Financial Health
Profit Margin (TTM) i0.11%0.09%
Operating Margin (TTM) i0.33%0.13%
Return on Equity (TTM) i0.04%0.13%
Debt to Equity (MRQ) i100.8432.95
Cash & Liquidity
Book Value per Share (MRQ)₹70.01₹178.28
Cash per Share (MRQ)₹1.07₹10.22
Operating Cash Flow (TTM) i₹74.16M₹282.88M
Levered Free Cash Flow (TTM) i₹18.39M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Auro Laboratories Limited vs Innova Captab Ltd.

MetricAUROLAB (Apr 26, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i48.0831.20
Forward P/E iN/A21.90
PEG Ratio i0.011.33
Price to Sales (TTM) i5.482.76
Price to Book (MRQ) i3.574.05
Market Capitalization
Market Capitalization i₹1.56B₹41.43B
Enterprise Value i₹2.03B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i7.132.90
Enterprise to EBITDA i31.1420.49
Risk & Other Metrics
Beta i0.09-0.33
Book Value per Share (MRQ) i₹70.01₹178.28

Financial Statements Comparison: Auro Laboratories Limited vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAUROLAB (2025)INNOVACAP (2025)
Revenue/Sales i191.24M12.34B
Cost of Goods Sold i99.08M8.38B
COGS % of Revenue i51.8%67.9%
Gross Profit i92.16M3.96B
Gross Margin i48.2%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i23.07M1.65B
Operating Margin i12.1%13.4%
EBITDA i40.60M2.00B
EBITDA Margin i21.2%16.2%
Pre-Tax Income i18.81M1.71B
Pre-Tax Income % of Revenue i9.8%13.9%
Income Tax i421,000427.58M
Income Tax % of Revenue i0.2%3.5%
Net Income (Profit) i18.39M1.28B
Profit Margin i9.6%10.4%

Balance Sheet & Liquidity Metrics

MetricAUROLAB (2025)INNOVACAP (2025)
Cash & Equivalents i3,000155.19M
Total Current Assets i215.14M7.03B
Total Current Assets % of Revenue i112.5%57.0%
Total Current Liabilities i216.42M3.53B
Total Current Liabilities % of Revenue i113.2%28.6%
Long-Term Debt i330.85M2.45B
Long-Term Debt % of Revenue i173.0%19.8%
Total Shareholders Equity i429.68M9.59B
Retained Earnings i359.52M4.53B
Retained Earnings % of Revenue i188.0%36.7%
Property, Plant & Equipment i16.55M442.93M

Cash Flow Statement Comparison

MetricAUROLAB (2025)INNOVACAP (2025)
Operating Cash Flow i74.16M282.88M
Operating Cash Flow % of Revenue i38.8%2.3%
Capital Expenditures i20,000-1.72B
Free Cash Flow i-180.54M-1.09B
FCF Margin i-94.4%-8.8%
Debt Repayment i0-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAUROLABINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.23M57.22M
Float Shares i2.35M15.91M
% Held by Insiders i60.96%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i39.04%8.59%

Dividend Analysis & Yield Comparison: Auro Laboratories Limited vs Innova Captab Ltd.

MetricAUROLABINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026